Insider Transactions in Q3 2021 at Standard Biotools Inc. (LAB)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 20
2021
|
Nicholas Khadder SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,013
-2.54%
|
$12,078
$6.53 P/Share
|
|
Aug 20
2021
|
Nicholas Khadder SVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
4,062
+4.88%
|
-
|
|
Aug 20
2021
|
Vikram Jog Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,378
-1.86%
|
$14,268
$6.53 P/Share
|
|
Aug 20
2021
|
Vikram Jog Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,879
+1.79%
|
-
|
|
Aug 20
2021
|
Stephen Christopher Linthwaite President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,287
-3.58%
|
$67,722
$6.53 P/Share
|
|
Aug 20
2021
|
Stephen Christopher Linthwaite President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,417
+2.37%
|
-
|
|
Aug 20
2021
|
Bradley Allen Kreger SVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,680
-3.18%
|
$16,080
$6.53 P/Share
|
|
Aug 20
2021
|
Bradley Allen Kreger SVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
7,753
+3.06%
|
-
|
|
Aug 20
2021
|
Colin Mc Cracken Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,523
-5.6%
|
$21,138
$6.53 P/Share
|
|
Aug 20
2021
|
Colin Mc Cracken Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,519
+3.45%
|
-
|